<DOC>
	<DOCNO>NCT02508506</DOCNO>
	<brief_summary>This study evaluate effect various degree renal function pharmacokinetics safety ALKS 5461 .</brief_summary>
	<brief_title>Pharmacokinetics Safety ALKS 5461 Subjects With Renal Impairment Normal Renal Function</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>For subject : Has body mass index ( BMI ) 18.040.0 kg/m^2 total body weight &gt; 50kg Agrees use approve method contraception duration study Additional criterion may apply For subject renal impairment : Has severe end stage renal disease , require dialysis Has stable renal function least 60 day precede screen Additional criterion may apply For subject : Has past history current finding clinically significant observed abnormality , psychiatric medical condition renal impairment Has history gastrointestinal surgery affect drug absorption biliary elimination , exclude appendectomy cholecystectomy Is pregnant , plan become pregnant , lactate Has history clinically significant allergy hypersensitivity opioids Additional criterion apply For subject renal impairment : Has evidence compromise respiratory function , seizure disorder , myasthenia gravis Has receive kidney transplant Additional criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>ALKS 5461</keyword>
	<keyword>Alkermes</keyword>
	<keyword>Samidorphan</keyword>
	<keyword>Renal Impairment</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Buprenorphine</keyword>
</DOC>